高管访谈视频:SPT Labtech与10x Genomics探讨单细胞工作流程自动化 - GenomeWeb
Executive Q&A Video: SPT Labtech and 10x Genomics on Automating Single-Cell Workflows - GenomeWeb
生物技术与制药领域的最新动态
Executive Q&A Video: SPT Labtech and 10x Genomics on Automating Single-Cell Workflows - GenomeWeb
BofA Securities Maintains 10x Genomics(TXG.US) With Hold Rating, Announces Target Price $18 - 富途牛牛
10x Genomics price target raised to $22 from $17 at Barclays - TipRanks
Spatial Transcriptomics Market Is Going to Boom |• 10X Genomics • Illumina - openPR.com
10x Genomics $TXG Position Increased by Nikko Asset Management Americas Inc. - MarketBeat
Why The Narrative Around 10x Genomics Is Shifting After New Institutional Buying And Product Updates - Yahoo Finance
Bellevue Group AG Buys 95,754 Shares of 10x Genomics $TXG - MarketBeat
Citi downgrades 10x Genomics (TXG) to a Hold - The Globe and Mail
10x Genomics (TXG) Q4 2024 Earnings Transcript - AOL.com
10x Genomics (TXG) Q2 2025 Earnings Transcript - AOL.com
TXG: Citigroup Downgrades 10x Genomics to Neutral with $18 Price Target | TXG Stock News - GuruFocus
10x Genomics (TXG) Q2 2025 Earnings Transcript - The Motley Fool
Citi Downgrades 10x Genomics(TXG.US) to Hold Rating, Raises Target Price to $18 - 富途牛牛
Why 10x Genomics (TXG) Stock Is Nosediving - Finviz
10x Genomics downgraded to Neutral from Buy at Citi - TipRanks
Why 10x Genomics (TXG) Stock Is Nosediving - TradingView — Track All Markets
Why 10x Genomics (TXG) Stock Is Nosediving - Yahoo Finance
Why 10x Genomics (TXG) Stock Is Nosediving - Markets Financial Content
10x Genomics Shares Slide Amid Downgrade and Insider Selling - TipRanks
Citigroup Downgrades 10x Genomics to Neutral From Buy, Price Target is $18 - marketscreener.com